Advertisement

Evaluation of the safety of paclitaxel eluting medical devices to treat peripheral arterial disease – The DETECT “Drug EluTing dEvices FrenCh safeTy survey” national study

      A meta-analysis published in 2018 concluded that mid-term and long-term mortality was higher in patients treated with paclitaxel eluting balloons and stents than in those treated with bare devices after the endovascular treatment of femoropopliteal lesions. There are no national data concerning the safety of these devices. We designed the DETECT (Drug EluTing dEvices FrenCh safeTy survey) study in order to compare the risk of mortality in patients treated with paclitaxel eluting balloons and/or stents or with bare devices.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Annals of Vascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect